Guangzhou Baiy reported CNY41.89B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Aspen Pharmacare ZAR 81.09B 3.81B Dec/2025
Cipla INR 344.32B 15.13B Mar/2026
Dr.Reddys Laboratories INR 378.92B 3.16B Mar/2026
Jiangsu Hengrui CNY 63.63B 2.35B Mar/2026
Kalbe Farma IDR 24.8T 611.2B Sep/2025
Richter Gedeon HUF 1.46T 59.22B Mar/2026
Sh Fosun Pharma CNY 49.15B 248.15M Mar/2026
Sh Pharmaceutical CNY 76.4B 615.53M Dec/2025
Sun Pharmaceuticals INR 835.7B 57.5B Mar/2026
Teva Pharmaceutical Industries USD 8.23B 314M Mar/2026